Login to Your Account



Search

Search results

Pharma: Clinic roundup

Takeda Pharmaceutical Co. Ltd. , of Osaka, Japan, said vedolizumab, a humanized monoclonal antibody antagonizing alpha4beta7 intregrin for treating moderate and severe ulcerative colitis and Crohn’s disease, entered two new Phase III trials in Japan. ...

BioWorld Today - Staff - 2014-01-09 01:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Takeda Pharmaceutical Co. Ltd. , of Osaka, Japan, reported top-line results from the GEMINI I Phase III study of vedolizumab in 895 patients with moderately to severely active ulcerative colitis who have failed at least one conventional thera ...

BioWorld Today - Staff - 2012-02-22 01:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• The ALS Therapy Development Institute (ALS TDI) said it plans to launch a Phase II trial of TDI 132 (fingolimod/Gilenya) in amyotrophic lateral sclerosis. Gilenya, a first-in-class sphingosine-1-phosphate (S1P) receptor modulator marketed by ...

BioWorld Today - Staff - 2012-02-15 01:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Eli Lilly and Co. , of Indianapolis, reported data from a Phase III study showing that both Cialis (tadalafil) and tamsulosin significantly improved scores on the International Prostate Symptom Score, compared to placebo, in men with signs an ...

BioWorld Today - Staff - 2012-02-08 01:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

Merck & Co. Inc., of Whitehouse Station, N.J., is collaborating with Glaxosmithkline plc, of London, to test Merck’s anti-PD-1 immunotherapy, MK-3475, with GSK’s oral kinase inhibitor, pazopanib, in advanced renal cell carcinoma. The compani ...

BioWorld Today - Staff - 2013-12-19 01:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Ipsen SA , of Paris, reported initial results from the 243-patient Phase III study of Dysport (abobotulinumtoxinA) in adult upper limb spasticity, showing statistically significant response vs. placebo in the improvement of muscle tone, as measured ...

BioWorld Today - Staff - 2013-12-18 01:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Asahi Kasei Pharma America Corp. , of Waltham, Mass., said it started an 800-patient Phase III trial of ART-123 (recombinant human thrombomodulin, sold as Recomodulin in Japan) in severe sepsis patients with coagulopathy. (BioWorld-T ...

BioWorld Today - Staff - 2012-11-01 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Boehringer Ingelheim GmbH , of Ingelheim, Germany, reported new data from its Phase III trial, Startverso, which evaluated faldaprevir in combination with pegylated interferon and ribavirin (PegIFN/RBV) in patients with genotype-1 hepatitis C (HCV) ...

BioWorld Today - Staff - 2013-12-17 01:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, reported results showing that pantoprazole magnesium 40 mg, branded Tecta, was as effective as esomeprazole 40 mg for achieving complete remission in patients with erosive gastroesophageal reflux disease, ...

BioWorld Today - Staff - 2013-12-16 01:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Mallinckrodt Inc. , of St. Louis, said the Phase III trial of MNK-155, an extended-release oral formulation of hydrocodone and acetaminophen, met the primary efficacy endpoint of change in pain from baseline over 48 hours compared to placebo in manag ...

BioWorld Today - Staff - 2013-12-13 01:00 - 0 comments - 0 attachments